Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06677333 · ClinicalTrials.gov registry record · NA

The Effect of Increasing Dietary Protein on the Gut Microbiome and Its Metabolites

A NA study of Health Adults, sponsored by Louisiana State University Health Sciences Center in New Orleans.

Completed
Registry status
NA
Development phase
87
Enrollment target
1
Study location

NCT06677333 is a NA study of Health Adults that has completed, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 87 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06677333, a NA study of Health Adults, has completed, sponsored by Louisiana State University Health Sciences Center in New Orleans.

COMPLETED
Registry status
NA
Development phase
87 participants
Enrollment target
1
Study location

Study Summary

This study will determine the effect of dietary protein not absorbed in the small intestine on the bacteria in the large intestine and the metabolites those bacteria produce when they break down the protein. The three specific goals are: 1. Determine if increasing dietary protein increases the purine breakdown product, allantoin, as observed in our previous study. 2. Establish a model to examine the effect of dietary protein on the gut microbiota and metabolites. 3. Identify gut bacteria and metabolite changes that occur with increased consumption of animal (whey) or plant (pea) protein sources.

Conditions Studied

Interventions

  • OTHER Whey Protein
  • OTHER Pea protein

Study Locations (1)

Louisiana

  • Louisiana State University Health Sciences Center New Orleans - New Orleans

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2023-02-01
Est. Completion 2023-11-30
Phase NA

What the Registry Record Tells You About NCT06677333

The ClinicalTrials.gov registry entry for NCT06677333 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center in New Orleans, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Health Adults appearing as the primary indexed condition, and to 2 interventions - of which Whey Protein is the first listed.

NCT06677333 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT06677333 about?

NCT06677333 is a clinical study titled "The Effect of Increasing Dietary Protein on the Gut Microbiome and Its Metabolites". This study will determine the effect of dietary protein not absorbed in the small intestine on the bacteria in the large intestine and the metabolites those bacteria produce when they break down the protein. The three specific goals are: 1. Determine if increasing dietary protein increases the puri...

What is the current status of trial NCT06677333?

This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2023-02-01. Estimated completion is 2023-11-30.

What conditions does trial NCT06677333 study?

This clinical trial studies the following conditions: Health Adults.

What interventions are being tested in trial NCT06677333?

The interventions under investigation include: Whey Protein (OTHER), Pea protein (OTHER).

Who is sponsoring clinical trial NCT06677333?

This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06677333 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.